Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1993 1
1996 1
1998 1
1999 1
2000 1
2001 1
2003 1
2004 2
2005 4
2006 5
2007 3
2009 3
2010 2
2012 2
2013 2
2014 4
2017 1
2018 1
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research.
Kienle GS, Glockmann A, Schink M, Kiene H. Kienle GS, et al. J Exp Clin Cancer Res. 2009 Jun 11;28(1):79. doi: 10.1186/1756-9966-28-79. J Exp Clin Cancer Res. 2009. PMID: 19519890 Free PMC article. Review.
BACKGROUND: Viscum album L. extracts (VAE, European mistletoe) are a widely used medicinal plant extract in gynaecological and breast-cancer treatment. ...Search of databases, reference lists and expert consultations. Criteria-based assessment of methodological s
BACKGROUND: Viscum album L. extracts (VAE, European mistletoe) are a widely used medicinal plant extract in gynaecological and …
Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies.
Kienle GS, Kiene H. Kienle GS, et al. Integr Cancer Ther. 2010 Jun;9(2):142-57. doi: 10.1177/1534735410369673. Epub 2010 May 18. Integr Cancer Ther. 2010. PMID: 20483874 Free article. Review.
OBJECTIVE: To evaluate controlled clinical studies on the efficacy and effectiveness of Viscum album for quality of life (QoL) in cancer. ...They carried out a criteria-based assessment of methodological study quality. RESULTS: The authors identified 2 …
OBJECTIVE: To evaluate controlled clinical studies on the efficacy and effectiveness of Viscum album for quality of lif …
Long-Term Follow-up of a Randomized Study of Oral Etoposide versus Viscum album Fermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse.
Longhi A, Cesari M, Serra M, Mariani E. Longhi A, et al. Sarcoma. 2020 Apr 26;2020:8260730. doi: 10.1155/2020/8260730. eCollection 2020. Sarcoma. 2020. PMID: 32398946 Free PMC article.
BACKGROUND: In relapsed osteosarcoma, the 5-yr postrelapse disease-free survival (PRDFS) rate after the second relapse is <20%. In June 2007, a randomized study was started comparing oral etoposide vs Viscum album fermentatum Pini (an extract derive …
BACKGROUND: In relapsed osteosarcoma, the 5-yr postrelapse disease-free survival (PRDFS) rate after the second relapse is <20%. In June 2 …
Complementary and alternative medicine for cancer pain: an overview of systematic reviews.
Bao Y, Kong X, Yang L, Liu R, Shi Z, Li W, Hua B, Hou W. Bao Y, et al. Evid Based Complement Alternat Med. 2014;2014:170396. doi: 10.1155/2014/170396. Epub 2014 Apr 13. Evid Based Complement Alternat Med. 2014. PMID: 24817897 Free PMC article. Review.
No benefits were found for acupuncture (versus drug therapy or shame acupuncture), and the results were inconsistent for massage therapy, transcutaneous electric nerve stimulation (TENS), and Viscum album L plus cancer treatment. However, the evidence levels for the …
No benefits were found for acupuncture (versus drug therapy or shame acupuncture), and the results were inconsistent for massage therapy, tr …
Viscum album (L.) in experimental animal tumors: A meta-analysis.
Bonamin LV, de Carvalho AC, Waisse S. Bonamin LV, et al. Exp Ther Med. 2017 Jun;13(6):2723-2740. doi: 10.3892/etm.2017.4372. Epub 2017 Apr 21. Exp Ther Med. 2017. PMID: 28596809 Free PMC article.
Mistletoe (Viscum album L.) has been used as complementary anticancer treatment for ~100 years. ...However, few studies reported having performed random allocation and none reported blinding. ...
Mistletoe (Viscum album L.) has been used as complementary anticancer treatment for ~100 years. ...However, few studies
Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R, Ziegler R. Grossarth-Maticek R, et al. Arzneimittelforschung. 2007;57(10):665-78. doi: 10.1055/s-0031-1296666. Arzneimittelforschung. 2007. PMID: 18074761 Clinical Trial.
In the non-randomized studies Ovar and OvarMet, the results adjusted for relevant prognostic variables were 0.47 (0.31, 0.69) and 0.62 (0.37, 1.05). Psychosomatic self-regulation in the Iscador group increases significantly within 12 months on a scale from 1 to 6 co …
In the non-randomized studies Ovar and OvarMet, the results adjusted for relevant prognostic variables were 0.47 (0.31, 0.69) …
A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a Fermented Viscum album L. Extract (Iscador): An Update of Findings.
Ostermann T, Appelbaum S, Poier D, Boehm K, Raak C, Büssing A. Ostermann T, et al. Complement Med Res. 2020;27(4):260-271. doi: 10.1159/000505202. Epub 2020 Jan 10. Complement Med Res. 2020. PMID: 31927541 Free article. English.
METHODS: The databases Embase, PubMed, CAMbase, Scopus, AMED and Cochrane were searched for clinical studies on cancer patients treated with Iscador. Quality of studies and risk of bias were evaluated according to the Cochrane guidelines and the Newcastle Ottawa Sca …
METHODS: The databases Embase, PubMed, CAMbase, Scopus, AMED and Cochrane were searched for clinical studies on cancer patients treat …
Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
Melzer J, Iten F, Hostanska K, Saller R. Melzer J, et al. Forsch Komplementmed. 2009 Aug;16(4):217-26. doi: 10.1159/000226249. Epub 2009 Jul 17. Forsch Komplementmed. 2009. PMID: 19729932 Free article. Review.
EMBASE, MEDLINE; hand search: e.g. bibliographies; search terms: e.g. mistletoe). To be included, randomised or comparative clinical trials at least had to examine mistletoe preparations standardized according to manufacturing process and to describe interventions explicit …
EMBASE, MEDLINE; hand search: e.g. bibliographies; search terms: e.g. mistletoe). To be included, randomised or comparative clinical …
Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.
Tröger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M. Tröger W, et al. Eur J Cancer. 2013 Dec;49(18):3788-97. doi: 10.1016/j.ejca.2013.06.043. Epub 2013 Jul 24. Eur J Cancer. 2013. PMID: 23890767 Free article. Clinical Trial.
We compared the overall survival (OS) of patients receiving an extract of Viscum album [L.] (VaL) or no antineoplastic therapy. METHODS: This is a prospective, parallel, open label, monocentre, group-sequential, randomised phase III study. ...FINDINGS: …
We compared the overall survival (OS) of patients receiving an extract of Viscum album [L.] (VaL) or no antineoplastic therapy …
Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients.
Thronicke A, Reinhold T, von Trott P, Grah C, Matthes B, Matthes H, Schad F. Thronicke A, et al. PLoS One. 2020 Jul 27;15(7):e0236426. doi: 10.1371/journal.pone.0236426. eCollection 2020. PLoS One. 2020. PMID: 32716969 Free PMC article.
BACKGROUND: For stage IV lung cancer patients receiving add-on Viscum album L. (VA) treatment an improved overall survival was detected. ...Further randomized and prospective cost-effectiveness studies are necessary to complement our findings....
BACKGROUND: For stage IV lung cancer patients receiving add-on Viscum album L. (VA) treatment an improved overall survival was …
33 results